Deamidated Gliadin Peptide Antibodies; is the Time to Use as a Routine Test for Celiac Disease

Mohammad Rostami Nejad^1,

¹Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Cite this paper:
Mohammad Rostami Nejad. Deamidated Gliadin Peptide Antibodies; is the Time to Use as a Routine Test for Celiac Disease. International Journal of Celiac Disease. 2017; 5(3):95-96. doi: 10.12691/ijcd-5-3-6

Abstract

Antibodies to deamidated gliadin peptides (DGP-AGA) have newly been presented into the extensive variety of serologic examinations for celiac disease (CD). In compare with the modern AGA, DGP-AGA indicated a higher sensitivity and specificity for CD and simply identified by ELISA kits. Nevertheless, even though the very favorable outcomes, DGP-AGA are not yet regularly used in the serologic checkup for CD. An antibody approach could initiate development in the diagnostic precision of serology for CD screening.

Keywords:
deamidated gliadin peptides celiac disease serologic checkup

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	Rostami Nejad, M. Celiac disease and non-celiac gluten sensitivity; evidences and differences. International Journal of Celiac Disease 2013;1(1): 6-7.
[2]	Zali MR, Rostami Nejad M, Rostami K, Alavian SM. Liver complications in celiac disease. Hepat Mon. 2011;11(5):333-41.
[3]	Gatselis NK, Zachou K, Norman GL, Tzellas G, Speletas M, Gabeta S, et al. IgA antibodies against deamidated gliadin peptides in patients with chronic liver diseases. Clinica chimica acta; international journal of clinical chemistry. 2012.
[4]	Naiyer AJ, Hernandez L, Ciaccio EJ, Papadakis K, Manavalan JS, Bhagat G, et al. Comparison of commercially available serologic kits for the detection of celiac disease. J Clin Gastroenterol. 2009;43(3):225-32.
[5]	Volta U, Granito A, Parisi C, Fabbri A, Fiorini E, Piscaglia M, et al. Deamidated gliadin peptide antibodies as a routine test for celiac disease: a prospective analysis. J Clin Gastroenterol. 2010;44(3):186-90.
[6]	Rashtak S, Ettore MW, Homburger HA, Murray JA. Combination testing for antibodies in the diagnosis of coeliac disease: comparison of multiplex immunoassay and ELISA methods. Aliment Pharmacol Ther. 2008;28(6):805-13.
[7]	Volta U, Fabbri A, Parisi C, Piscaglia M, Caio G, Tovoli F, et al. Old and new serological tests for celiac disease screening. Expert Rev Gastroenterol Hepatol. 2010;4(1):31-5.
[8]	Samaşca G, Iancu M, Butnariu A, Andreica M, Dejica D. New Para-Clinical Investigations in the Celiac Disease. Romanian Rev Lab Med 2010;18(2):43-51.
[9]	Marti CO, Fellay B, Bürgin-Wolff A, Magnin J-L, Baehler P. Evaluation of a DGP Point-of-care Test for Celiac Disease in a Pediatric Population. International Journal of Celiac Disease. 2015;3(1):7-11.
[10]	Hong YY. Deaminated Gliadin Peptide Antibody in the Diagnosis of Celiac Disease. International Journal of Celiac Disease. 2015:3(2):56-57.